ARTICLE | Clinical News
CDX-301: Pilot trial started
October 6, 2014 7:00 AM UTC
Celldex began an open-label, U.S. pilot trial to evaluate CDX-301 for 5 or 7 days alone and in combination with Mozobil plerixafor in up to 18 human leukocyte antigen (HLA)-matched donor/recipient s...